Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Cell Mol Pharmacol 7: 190,

Genomic Revolution Recombinant DNA Technology and the Human Genome Project

Michael Moura*
Department of Materials Science and Engineering, National Taiwan University of Science and Technology, Germany
*Corresponding Author : Michael Moura, Department of Materials Science and Engineering, National Taiwan University of Science and Technology, Germany, Email: monireh.soltani@gmail.com

Received Date: Dec 01, 2024 / Published Date: Dec 29, 2023

Abstract

The Genomic Revolution, driven by Recombinant DNA Technology and the Human Genome Project (HGP), represents a watershed moment in molecular biology. This article explores the foundational role of Recombinant DNA Technology in manipulating genetic material and its synergy with the Human Genome Project, a collaborative endeavor that mapped and sequenced the entire human genome. The unraveling of the genetic code has provided unprecedented insights into human biology, enabling breakthroughs in personalized medicine and raising ethical considerations. As we navigate the implications of genomic advancements, including the emergence of CRISPR and other gene-editing technologies, a delicate balance between scientific progress and ethical responsibility becomes paramoun

Citation: Moura M (2023) Genomic Revolution Recombinant DNA Technology andthe Human Genome Project. J Cell Mol Pharmacol 7: 190.

Copyright: © 2023 Moura M. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top